This inventor holds 1 USPTO granted patent. Top assignees: Biopoa, Inc., Kbnp, Inc.. Active years: 2012.
Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2012
Title: Mi-Joung Ko: Innovator in Vaccine Development
Introduction
Mi-Joung Ko is a notable inventor based in Siheung, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines. His work focuses on creating innovative solutions to combat infectious diseases.
Latest Patents
Mi-Joung Ko holds a patent for an "Attenuated recombinant Newcastle disease virus and vaccine containing the same." This invention relates to a recombinant vector for the transcription of the Newcastle disease virus (NDV) genome. It includes a strain of attenuated recombinant NDV with a surface antigen of pathogenic NDV. The patent outlines a method for preparing a recombinant NDV that has low pathogenicity and high protective efficiency against Newcastle disease (ND). Additionally, it describes a vaccine against ND that contains the recombinant NDV. He has 1 patent to his name.
Career Highlights
Throughout his career, Mi-Joung Ko has worked with various companies, including Kbnp, Inc. and Biopoa, Inc. His experience in these organizations has contributed to his expertise in vaccine development and virology.
Collaborations
Mi-Joung Ko has collaborated with several professionals in his field, including Young-Jin An and Young-Ho Park. These collaborations have likely enhanced his research and development efforts.
Conclusion
Mi-Joung Ko is a prominent figure in the field of vaccine innovation, with a focus on Newcastle disease. His contributions through patents and collaborations highlight his commitment to advancing medical science.